Pentalgin Tablets p / o, # 4
Category
Pain relievers
,
Migraine
Scope of the medicinal product
General
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
4
Pentalgin tab.
p / o captivity.
# 4
Name ENG
PENTALGIN
Clinical and pharmacological group
Spasmodic analgesic
ATX code
Paracetamol in combination with psycholeptics
Dosage
1 tab.
paracetamol 325 mg, naproxen 100 mg, caffeine 50 mg, drotaverine hydrochloride 40 mg, pheniramine maleate 10 mg
Structure
Active ingredients: paracetamol 325 mg
naproxen 100 mg
caffeine 50 mg
drotaverine hydrochloride 40 mg
pheniramine maleate 10 mg
Excipients: microcrystalline cellulose, potato starch, croscarmellose sodium, hyprolose (hydroxypropyl cellulose) (clocel EF), citric acid monohydrate, butyl hydroxytoluene (E321), magnesium stearate, talc, quinoline yellow dye E13 E2104)
The composition of the film shell: hypromellose (hydroxypropyl methylcellulose), povidone (medium molecular weight polyvinylpyrrolidone), polysorbate 80 (tween 80), titanium dioxide, talc, quinoline yellow dye (E104), indigo carmine (E132)
Indications
pain syndrome of various origins, including pain in joints, muscles, sciatica, algodismenorrhea, neuralgia, toothache, headache (including those caused by cerebral vasospasm)
pain syndrome associated with spasm of smooth muscles, incl.
with chronic cholecystitis, cholelithiasis, postcholecystectomy syndrome, renal colic
post-traumatic and postoperative pain syndrome, incl.
accompanied by inflammation
colds accompanied by a febrile syndrome (as symptomatic therapy).
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
INN / Active ingredient
Paracetamol, Naproxen, Caffeine, Drotaverine, Pheniramine
Contraindications
erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase)
gastrointestinal bleeding
complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and paranasal sinuses and intolerance to acetylsalicylic acid or other NSAIDs (including history)
severe liver failure
severe renal failure
oppression of bone marrow hematopoiesis
condition after coronary artery bypass grafting
severe organic diseases of the cardiovascular system (including acute myocardial infarction)
paroxysmal tachycardia
frequent ventricular premature beats
severe arterial hypertension
hyperkalemia
hypersensitivity to drug components.
With caution: the drug should be used in patients with cerebrovascular diseases, diabetes mellitus, diseases of peripheral arteries, history of gastrointestinal ulcers, with mild or moderate renal and hepatic insufficiency, viral hepatitis, alcoholic liver damage, benign hyperbilirubinemia (Gilbert's, Dubin's syndromes Johnson and Rotor), epilepsy, with a tendency to seizures, deficiency of glucose-6-phosphate dehydrogenase, in elderly patients.
In the presence of any of the listed diseases and conditions, the patient should consult a doctor before using the drug.
Specifications
Category
Pain relievers
,
Migraine
Scope of the medicinal product
General
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
4
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
OTCPharm
The amount of the dosage form in the primary package
4 things.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Dosage form
Film-coated tablets
Packaging
Box
The target audience
Adult
Expiration date in days
730
Package weight, g
ten
Mode of application
:
The drug is prescribed orally 1 tablet 1-3 times a day.
The maximum daily dose is 4 tablets.
The duration of treatment is no more than 3 days as an antipyretic agent and no more than 5 days as a pain reliever.
Continuation of drug treatment is possible only after consulting a doctor.
Do not exceed the indicated dose of the drug.
Pharmaco-therapeutic group
:
Analgesic (non-narcotic analgesic + NSAID + psychostimulant + antispasmodic + H1-histamine receptor blocker)
Anatomical and therapeutic characteristics
:
N02BE71 Paracetamol, in combination with psychotropic drugs
Dosage (volume) of the substance in the preparation
:
1 tab.
paracetamol 325 mg, naproxen 100 mg, caffeine 50 mg, drotaverine hydrochloride 40 mg, pheniramine maleate 10 mg